Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Sacituzumab Govitecan for Breast Cancer
Recruiting2 awardsPhase 3
Saint Petersburg, Florida
This trial will compare a new drug (SG) to current treatments for metastatic breast cancer to see if it can improve life spans. Primary objective is to compare its effect on progression-free survival (PFS).
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service